SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Nucleic acid amplification technology screening for hepatitis C virus and human immunodeficiency virus for blood donations
4 references·1 citing·16 second hop
Nucleic acid amplification technology screening for hepatitis C virus and human immunodeficiency virus for blood donations (2006)Nucleic acid amplification technology scr…Impact of nucleic acid amplification technology (NAT) in Italy in the three years following implementation (2001-2003) (2005)Impact of nucleic acid amplif…Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia (2004)Prevalence of HBV, HCV, HIV-1…Biological qualification of blood units (2004)Biological qualification of b…Transfusion risks of yesterday and of today (2003)Transfusion risks of yesterda…Seroprevalence of transfusion-transmitted infections among blood donors in Makkah, Saudi Arabia (2024)Seroprevalence of transfusion…Nucleic acid amplification testing of blood donors fortransfusion‐transmitted infectious diseases (2000)International application of the Incidence Rate/Window Period model (2002)Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window‐phase donations not detected by NAT (2002)The risks of transfusion-transmitted infection: direct estimation and mathematical modelling (2000)Safety of blood supply in the Caribbean countries: Role of screening blood donors for markers of hepatitis B and C viruses (2005)Detection of HIV‐1 infection in blood donors during the immunological window period using the nucleic acid‐amplification technology (2007)Modeling the transmission risk of emerging infectious diseases through blood transfusion (2012)Prevalence of seromarkers of HBV and HCV among blood donors in eastern Saudi Arabia, 1998-2001 (2004)Blood transfusion during the COVID-19 outbreak. (2020)Management of blood supply and demand during the COVID-19 pandemic in King Abdullah Hospital, Bisha, Saudi Arabia (2020)Public health research literature on infectious diseases: coverage and gaps in Europe (2007)Human immunodeficiency virus type 1 incidence among blood donors in France, 1992 through 2006: use of an immunoassay to identify recent infections (2008)Residual risk of transmission of human immunodeficiency virus and hepatitis C virus infections by blood transfusion in northern Brazil (2017)Bloodborne infections among student voluntary blood donors in Mansoura University, Egypt. (2006)Transfusion transmitted infections – A retrospective analysis from the National Blood Transfusion Service in Eritrea (2011)Association of ABO and Rh Blood Groups to Blood-Borne Infections among Blood Donors in Tehran-Iran. (2014)
this work references cited by second hop

References

  • 2004Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia121 cited
  • 2003Transfusion risks of yesterday and of today53 cited
  • 2005Impact of nucleic acid amplification technology (NAT) in Italy in the three years following implementation (2001-2003)37 cited
  • 2004Biological qualification of blood units29 cited

Cited by

  • 2024Seroprevalence of transfusion-transmitted infections among blood donors in Makkah, Saudi Arabia8 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work